These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8625754)

  • 1. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
    Weizman Z
    Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
    Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
    Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis.
    Durie PR; Gaskin KJ; Geokas MC; O'Rourke M; Largman C
    J Pediatr Gastroenterol Nutr; 1982; 1(3):337-43. PubMed ID: 7186046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of food intake and cholecystokinin on plasma trypsinogen levels in dogs.
    Reidelberger RD; O'Rourke M; Durie PR; Geokas MC; Largman C
    Am J Physiol; 1984 May; 246(5 Pt 1):G543-9. PubMed ID: 6326612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma immunoreactive-trypsin(ogen) levels during development.
    Levine JJ; Udall JN; Bloch KJ; Hanson DG; James BC; Walker WA
    J Pediatr Gastroenterol Nutr; 1988; 7(3):406-10. PubMed ID: 3260281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive trypsin(ogen) in the sera of children with recent-onset insulin-dependent diabetes and matched controls. The Swedish Childhood Diabetes Group.
    Landin-Olsson M; Borgström A; Blom L; Sundkvist G; Lernmark A
    Pancreas; 1990 May; 5(3):241-7. PubMed ID: 2188253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chronically reserpinized rat as a model for cystic fibrosis: alterations in pancreatic enzyme secretion and storage.
    McCurdy RE; Martinez R
    Pediatr Res; 1981 Sep; 15(9):1308-13. PubMed ID: 6170040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
    Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
    Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exocrine pancreatic secretion in pigs fed sow's milk and milk replacer, and its relationship to growth performance.
    van den Borne JJ; Weström BR; Kruszewska D; Botermans JA; Svendsen J; Woliński J; Pierzynowski SG
    J Anim Sci; 2007 Feb; 85(2):404-12. PubMed ID: 17235025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function.
    Hazlett D; Korc M; Brannon PM
    Pediatr Res; 1986 Dec; 20(12):1236-9. PubMed ID: 2432455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis.
    Moore DJ; Forstner GG; Largman C; Cleghorn GJ; Wong SS; Durie PR
    Gut; 1986 Nov; 27(11):1362-8. PubMed ID: 3792918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
    Geokas MC; Largman C; Brodrick JW; Johnson JH
    Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exocrine pancreatic secretion in rats treated with reserpine after stimulation with pilocarpine, dopamine, and caerulein.
    Morton D; Parker A; Estrada P; Martinez JR
    Pediatr Res; 1980 Jan; 14(1):18-20. PubMed ID: 6153788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of pancreatic amylase secretion in the reserpinized rat model of cystic fibrosis. Effects of cerulein and EGF.
    Morisset J; Bérubé FL; Vanier M; Benrezzak O
    Int J Pancreatol; 1994 Aug; 16(1):37-44. PubMed ID: 7528761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radio-immuno-assay for trypsin in newborn-screening for cystic fibrosis].
    Sander J; Niehaus C
    Monatsschr Kinderheilkd; 1982 Nov; 130(11):843-5. PubMed ID: 7155149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypsinogen is not activated during cardiac surgery with extracorporeal circulation.
    Jönsson P; Borgström A; Steen S; Ohlsson K
    Scand J Clin Lab Invest; 1995 Aug; 55(5):441-5. PubMed ID: 8545603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific immunoradiometric assay of cationic trypsin(ogen) that does not recognize trypsin-alpha-1-proteinase inhibitor complex.
    Lafont P; Guy-Crotte O; Paulin C; Galvain D; Mertani S; Figarella C; Barbier Y
    Clin Chim Acta; 1995 Mar; 235(2):197-206. PubMed ID: 7554274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chronically reserpinized rat as a possible model for cystic fibrosis. VII. Alterations in the secretory response to cholecystokinin and to secretin from the pancreas in vivo.
    Perlmutter J; Martinez JR
    Pediatr Res; 1978 Mar; 12(3):188-94. PubMed ID: 643388
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated serum levels of immunoreactive anionic trypsin (but not cationic trypsin) signals pancreatic disease.
    Borgström A; Andrén-Sandberg A
    Int J Pancreatol; 1995 Dec; 18(3):221-5. PubMed ID: 8708393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.